This randomized split-mouth clinical trial aims to evaluate the clinical performance of bioactive restorative materials used in Class II restorations in permanent posterior teeth. The study compares a giomer-based bulk-fill restorative material, a giomer restorative material, and a resin-modified glass ionomer cement in terms of clinical success and overall clinical performance. Patients requiring at least three Class II restorations in posterior teeth are treated under standardized clinical conditions. Clinical evaluations are performed at baseline and follow-up visits to assess short- and long-term outcomes.
Who can participate
Age range18 Years β 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Healthy individuals without any systemic disease that could contraindicate restorative treatment
β. Individuals aged between 18 and 50 years
β. Individuals who agreed to participate in the study and signed the informed consent form
β. Individuals with at least three proximal carious lesions in premolar or molar teeth, classified as D2 (lesions extending to the middle third of dentin) or D3 (lesions extending to the inner third of dentin) according to the ICDAS classification
β. Teeth with intact enamel and dentin structure that had not been previously restored
β. Individuals who brushed their teeth at least twice a day
β. Individuals without physical disabilities that could prevent attendance at follow-up visits
β. Individuals with at least 20 teeth in occlusion and with antagonist teeth in the opposing arch